Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group study. [electronic resource]
Producer: 20020830Description: 2645-52 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Aged, 80 and over
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Daunorubicin -- administration & dosage
- Dexamethasone -- administration & dosage
- Drug Therapy, Combination
- Female
- Humans
- Liposomes
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.